Edwards Lifesciences (EW) Enters $325M Accelerated Share Repurchase Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NRIX
6. SUNS
7. CRDO
8. OIG
9. SPY
10. SNDX

Go back to Edwards Lifesciences (EW) Enters $325M Accelerated Share Repurchase Agreement

Canaccord Genuity Raises Price target on Edwards Lifesciences (EW) as TAVI Continues to Grow

February 3, 2016 10:06 AM EST

Canaccord Genuity reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $92.00 (from $90.00), following the company's 4Q. Checks imply growing acceptance of TAVI as a durable therapy for severe, symptomatic aortic valve disease, with predictable outcomes and consistent results rapidly... More

Edwards Lifesciences (EW) PT, Estimate Raised at Piper Jaffray on Strong 2015 Finish

February 3, 2016 7:42 AM EST

Piper Jaffray analyst Brooks West reiterated an Overweight rating and boosted his price target on Edwards Lifesciences (NYSE: EW) to $97.00 (from $90.00) following a strong finish to 2015 and higher 2016 guidance.

West commented, "Edwards reported Q4 revenues of $671.1M, beating our estimate of $647.7M and consensus $648.8M. Upside... More